| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.076 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |